Global Clinical Trial Imaging Market

Global clinical trial imaging market by service (clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, others), by application (cardiology, endocrinology, gastroenterology, neurology, oncology, others), by end user (academia and research institutes, contract research organizations (CROs), medical device companies, pharmaceutical & biotechnology companies, others), by region (North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America), outlook & forecast, 2023-2029

Report Code: GH03918R Industry: Region:
Description

Imaging was identified as one of the components that could play an important role in reducing the cost of clinical trials, which is a major component of drug approval costs. In particular, using time-to-progression (often detected by imaging) rather than survival as the outcome measure can reduce costs and improve timeliness. Gen Consulting Company predicts the global clinical trial imaging market will grow from USD 1,176 million in 2022 to USD 1,669 million by 2029, achieving a compound annual growth rate (CAGR) of 5.2 percent.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global clinical trial imaging market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, application, end user, and region. The global market for clinical trial imaging can be segmented by service: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, others. The project and data management services segment held the largest share of the global clinical trial imaging market in 2022 and is anticipated to hold its share during the forecast period. Clinical trial imaging market is further segmented by application: cardiology, endocrinology, gastroenterology, neurology, oncology, others. Globally, the oncology segment made up the largest share of the clinical trial imaging market. Based on end user, the clinical trial imaging market is segmented into: academia and research institutes, contract research organizations (CROs), medical device companies, pharmaceutical & biotechnology companies, others. The CROs segment was the largest contributor to the global clinical trial imaging market in 2022. On the basis of region, the clinical trial imaging market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global clinical trial imaging market.

Market Segmentation
By service: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, others
By application: cardiology, endocrinology, gastroenterology, neurology, oncology, others
By end user: academia and research institutes, contract research organizations (CROs), medical device companies, pharmaceutical & biotechnology companies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global clinical trial imaging market report offers detailed information on several market vendors, including Biospective Inc., Biotelemetry Inc. (Koninklijke Philips N.V.), Cardiovascular Imaging Technologies LLC (CVIT), ERT + Bioclinica, Inc. (Clario), ICON plc, Imaging Endpoints II LLC, Intrinsic Imaging LLC (WIRB – Copernicus Group, Inc.), IXICO plc, Median Technologies S.A., Medical Metrics Inc. (Catalent, Inc.), Medpace Holdings, Inc., Micron Inc., Parexel International Corporation, Perceptive Informatics, LLC D/B/A Calyx, pharmtrace klinische Entwicklung GmbH, Prism Clinical Imaging, Inc., ProScan Imaging LLC, Radiant Sage LLC, Resonance Health Ltd., WorldCare Clinical, LLC, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global clinical trial imaging market.
• To classify and forecast the global clinical trial imaging market based on service, application, end user, region.
• To identify drivers and challenges for the global clinical trial imaging market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trial imaging market.
• To identify and analyze the profile of leading players operating in the global clinical trial imaging market.

Why Choose This Report
• Gain a reliable outlook of the global clinical trial imaging market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Global Clinical Trial Imaging Market

Interested in this report? Get your FREE sample now!

$2,850.00

Code: GH03918R Industry: Region:

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Global Clinical Trial Imaging Market

Please fill out our form and we will get back to you.